Kynam Capital Management, LP Vertex Pharmaceuticals Inc Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
A detailed history of Kynam Capital Management, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kynam Capital Management, LP holds 100,000 shares of VRTX stock, worth $46.9 Million. This represents 4.39% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$46.9 Million% of portfolio
4.39%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VRTX
# of Institutions
1,623Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.63 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.33 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...